title: [The use of an early postoperative interstitial-hyperthermia combination therapy in malignant gliomas].
abstract: BACKGROUND
  The survival of people suffering from malignant gliomas (WHO level III and IV) is predominantly limited by local progress in the primary tumor region. Interstitial hyperthermia combined with radiotherapy or chemotherapy is one approach for the intensification of local therapy. It is possible to combine (partial) tumor resection with hyperthermia as well as with brachytherapy by implanting catheters intraoperatively.
  
  
  METHODS
  A pilot study was performed to examine practicality, tolerability, effectiveness and scope for improvement in early postoperative hyperthermia treatment following catheter implantation as part of (partial) tumor resection. Each CT data set was transferred into a VAX 3100 workstation for retrospective analysis of the hyperthermia treatment. The implanted catheters were segmented and the distributions of power density and temperature were simulated. We sought to achieve the best possible temperature distributions by optimising the catheter arrangement in the planning calculations. The corresponding Ir-192-source brachytherapy treatments were simulated in a similar way using the implanted, as well as optimised catheter arrays.
  
  
  RESULTS
  Intraoperative catheter implantation in 4 patients was problem-free. Postoperative complications were not observed, neither were infections. Interstitial microwave hyperthermia in combination with percutaneous irradiation or chemotherapy a few days after the operation was also tolerated well by all patients. Effective temperatures (of at least 42 degrees C) were regularly achieved at measurement points, but the temperature distributions were unsatisfactory, with T90 values (the temperature reached in at least 90% of the target volume) of under 38 degrees C. Measured temperature/position curves showed qualitative correlation with the simulated calculations. The catheter positions determined by optimisation varied significantly from the positions clinically used.
  
  
  CONCLUSIONS
  Early postoperative combination therapy using hyperthermia for the treatment of malignant gliomas is a very practical approach. The optimisation strategies described should be used preoperatively to plan catheter arrays for interstitial hyperthermia and brachytherapy, and these arrays should be implanted using stereotaxic surgery.
authors.affiliation: Strahlenklinik und Poliklinik, Virchow-Klinikum, Humboldt Universität zu Berlin.
authors.forename: H
authors.initials: H
authors.lastname: Stahl
authors.forename: P
authors.initials: P
authors.lastname: Wust
authors.forename: K
authors.initials: K
authors.lastname: Maier-Hauff
authors.forename: M
authors.initials: M
authors.lastname: Seebass
authors.forename: M
authors.initials: M
authors.lastname: Mischel
authors.forename: M
authors.initials: M
authors.lastname: Gremmler
authors.forename: G
authors.initials: G
authors.lastname: Golde
authors.forename: J
authors.initials: J
authors.lastname: Löffel
authors.forename: R
authors.initials: R
authors.lastname: Felix
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D001918:Brachytherapy / Q000379:methods; D001921:Brain / Q000000981:diagnostic imaging / Q000473:pathology; D001932:Brain Neoplasms / Q000175:diagnosis / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005910:Glioma / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D006979:Hyperthermia, Induced / Q000295:instrumentation / Q000379:methods*; D008279:Magnetic Resonance Imaging; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000628:therapy; D015376:Nimustine / Q000008:administration & dosage; D010865:Pilot Projects; D011182:Postoperative Care / Q000379:methods*; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D013997:Time Factors; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D015376:Nimustine
vernacular_title: Einsatz einer früh postoperativen interstitiellen Hyperthermiekombinationstherapie bei malignen Gliomen.